This webinar is organised by Merck in collaboration with UCL Partners.
What the data is telling us about Covid-19 in MS patients
In this webinar we will focus on the what the Italian and UK MS registry data is telling us about outcomes for MS patients with Covid-19 and what the implications might be as we reestablish MS services. Each panelist will deliver a short presentation, followed by a facilitated Q&A and online polling on the issues discussed.
- What the Italian MS registry data is telling us: Prof Maria Pia Sormani, University of Genoa
- The impact of Covid-19 on MS patients in the UK: Dr Nikos Evangelou, Consultant Neurologist Nottingham University Hospital
- Chaired by Dr Charlie Davie, Consultant Neurologist from UCLPartners
This one-hour webinar will be held at 5pm on Thursday 16 July 2020.
This webinar is aimed at individuals within AHSNs who have an interest in MS services and the MS clinical community, including MS neurologists, MS nurses and pharmacists. The main points from this webinar series will be made available in a short report.
This webinar and the associated report has been initiated, organised and funded by Merck Medical Affairs, in collaboration with UCLPartners. This is a non-promotional webinar.
Sign up for this event